Compumedics Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

David Burton

Chief Executive Officer (CEO)

AU$253.4k

Compensación total

Porcentaje del salario del CEO	90.1%
Permanencia del CEO	37.8yrs
Participación del CEO	53.4%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	7.9yrs

Actualizaciones recientes de la dirección

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Oct 24

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Oct 24

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

Jun 17

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Oct 14

Is Compumedics (ASX:CMP) Using Debt Sensibly?

May 02

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Dec 08

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Aug 09

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Jun 10

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

May 06

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

Feb 25

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Dec 01

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de David Burton en comparación con los beneficios de Compumedics?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jun 30 2024	AU$253k	AU$228k	-AU$338k
Mar 31 2024	n/a	n/a	AU$447k
Dec 31 2023	n/a	n/a	AU$1m
Sep 30 2023	n/a	n/a	-AU$2m
Jun 30 2023	AU$252k	AU$228k	-AU$6m
Mar 31 2023	n/a	n/a	-AU$6m
Dec 31 2022	n/a	n/a	-AU$6m
Sep 30 2022	n/a	n/a	-AU$2m
Jun 30 2022	AU$251k	AU$228k	AU$1m
Mar 31 2022	n/a	n/a	AU$663k
Dec 31 2021	n/a	n/a	-AU$31k
Sep 30 2021	n/a	n/a	AU$484k
Jun 30 2021	AU$244k	AU$223k	AU$998k
Mar 31 2021	n/a	n/a	-AU$2m
Dec 31 2020	n/a	n/a	-AU$5m
Sep 30 2020	n/a	n/a	-AU$5m
Jun 30 2020	AU$237k	AU$217k	-AU$6m
Mar 31 2020	n/a	n/a	-AU$1m
Dec 31 2019	n/a	n/a	AU$3m
Sep 30 2019	n/a	n/a	AU$4m
Jun 30 2019	AU$250k	AU$228k	AU$4m
Mar 31 2019	n/a	n/a	AU$3m
Dec 31 2018	n/a	n/a	AU$3m
Sep 30 2018	n/a	n/a	AU$3m
Jun 30 2018	AU$250k	AU$228k	AU$3m

Compensación vs. Mercado: La compensación total de David($USD167.81K) está por debajo de la media de empresas de tamaño similar en el mercado Australian ($USD299.68K).

Compensación vs. Ingresos: La compensación de David ha aumentado mientras la empresa no es rentable.

CEO

David Burton (65 yo)

37.8yrs

Permanencia

AU$253,391

Compensación

Dr. David Burton, Ph.D. founded Compumedics Ltd. in 1987 and serves as its Executive Chairman and Chief Executive Officer. Dr. Burton serves as Executive Chairman and Chief Executive Officer of Compumedics...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
David Burton	Founder	no data	AU$253.39k	53.35% A$ 29.9m
David Lawson	CFO, Company Secretary & Executive Director	11.1yrs	AU$389.91k	1.89% A$ 1.1m
Rodney North	Non-Executive Director	2.1yrs	AU$30.00k	0.0011% A$ 610.9
Patrice Bourgin	Member of Medical Advisory Board	7.9yrs	sin datos	sin datos
John Ebersole	Member of Medical Advisory Board	7.9yrs	sin datos	sin datos
Ian Colrain	Member of Medical Advisory Board	7.9yrs	sin datos	sin datos

7.9yrs

Permanencia media

Junta con experiencia: La junta directiva de CMP se considera experimentada (7.9 años de antigüedad promedio).

Compumedics Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Compumedics Limited, Annual General Meeting, Oct 31, 2024

Compumedics Limited, Annual General Meeting, Oct 31, 2023

No independent directors

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics Limited, Annual General Meeting, Oct 27, 2022

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in FY 2023)

Compumedics Limited, Annual General Meeting, Oct 31, 2024

Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.035 loss in FY 2023)

New minor risk - Shareholder dilution

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

New minor risk - Share price stability

Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)

New major risk - Share price stability

We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt

Full year 2023 earnings released: AU$0.035 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited, Annual General Meeting, Oct 31, 2023

Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited Provides Revenue Guidance for the Year 2023

Is Compumedics (ASX:CMP) A Risky Investment?

Compumedics Limited Re-Affirms Earnings Guidance for the Fiscal Year 2023

First half 2023 earnings released: AU$0.041 loss per share (vs AU$0.002 profit in 1H 2022)

Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company

Compumedics Limited Provides Revenue Guidance for the First Half of Fiscal Year 2023

No independent directors

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited, Annual General Meeting, Oct 27, 2022

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited Provides Revenue Guidance for the Fiscal Year 2023

Is Compumedics (ASX:CMP) Using Debt Sensibly?

No independent directors

Tucson Dunn Retires as Director of Compumedics Limited, Effective 31 March, 2022

First half 2022 earnings: EPS and revenues miss analyst expectations

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

New 90-day low: AU$0.41

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

First half 2021 earnings released: EPS AU$0.007 (vs AU$0.001 in 1H 2020)

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Price target lowered to AU$1.00

Compumedics Limited Announces Not to Provide Guidance for the Fiscal Year 2021

Compumedics Limited Announces That Sales Forecasts Will Remain Problematic Due to COVID-19 Pandemic

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media